Is Hims or Ro better for GLP-1 weight loss?

Ro is the better GLP-1 weight loss program for most ClearlyMeds readers because it matches Hims on entry price at $149/mo while adding coaching, broader medication access, and stronger insurance support.

Price is a tie, support is not

At the top-line price, Ro and Hims look identical because each starts at $149/mo. If you stopped there, the programs would appear interchangeable. ClearlyMeds does not see them that way. Ro includes coaching, lists oral and injectable options, and positions insurance support as a core part of the experience. Hims keeps the process simple and consumer-friendly, but it is more self-directed and lighter-touch.

That difference matters because GLP-1 success is not just about getting a prescription. Users often need help with dose titration questions, insurer paperwork, side-effect troubleshooting, or deciding whether to stay on an oral option versus moving to semaglutide. ClearlyMeds gives Ro the edge because its care model is built to do more of that work.

Where Hims can still be the better fit

ClearlyMeds would still pick Hims for some shoppers. If your main goal is a straightforward digital intake and you do not care about coaching, Hims may feel cleaner. The platform is simpler, the experience is less medicalized, and the decision path is easier for self-directed users. Someone who already knows what they want and just wants a friction-light online workflow may prefer Hims.

Hims also works for people who are cautious about overpaying for support they will not use. If you do not want coaching and you do not expect to need insurance navigation, the cleaner value proposition can be appealing.

Why ClearlyMeds usually favors Ro

ClearlyMeds usually recommends Ro because the incremental support is meaningful at the same starting price. Ro lists oral, semaglutide, and tirzepatide medication types in the dataset, while Hims lists oral and semaglutide. Ro also scores higher overall in the ClearlyMeds provider ratings. The difference reflects care breadth more than branding.

Ro is also the stronger pick if you are undecided about medication type. A user comparing oral versus injectable options has more room to change course inside Ro than inside Hims. The same is true for users whose budget depends on insurance help.

ClearlyMeds bottom line

ClearlyMeds would choose Ro for most GLP-1 shoppers because $149/mo buys more support, more medication flexibility, and better insurance navigation than Hims. ClearlyMeds would choose Hims only when the user explicitly wants a simpler, lighter-touch digital experience and is comfortable managing more of the journey independently.